People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Agriculture, Pharmaceuticals, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sound Agriculture Co | — | Agriculture | Series C | $176.2M | $138.4M | 2017 |
| Aratana Therapeutics, Inc. | — | Pharmaceuticals | Series B | $67.3M | $1.0B | 2010 |
| Allylix Inc. | — | Other | Series B | $34.2M | $41.5M | 2014 |
| EnEvolv, Inc. | — | Biotechnology | Seed | $1.8M | $79.7M | 2014 |
Ron Meeusen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ron Meeusen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sanjeev Krishnan | 1 | 11 |
| David Rosen | 1 | 10 |
| David Kabakoff | 1 | 7 |
| Jay Lichter | 1 | 7 |
| Jay Lichter, Ph.D. | 1 | 5 |
| Derek Norman | 1 | 5 |
| David Pierson | 1 | 5 |
| Clay Mitchell | 1 | 5 |
| Robert Gerber | 1 | 4 |
| Steven St. Peter | 1 | 4 |
| Craig Tooman | 1 | 3 |
| Marc Khouzami | 1 | 3 |
| Ryan Teksten | 1 | 3 |
| Simon Barnes | 1 | 2 |
| Adam Litle | 1 | 2 |
| Cheryl Martin | 1 | 2 |
| Colin Steen | 1 | 2 |
| Stephen A. Block | 1 | 2 |
| Paul Beck | 1 | 2 |
| Carolyn Fritz | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.